Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma (vol 24, pg 1649, 2018)

被引：11

作者：

Amaria, Rodabe N.

Reddy, Sangeetha M.

Tawbi, Hussein A.

Davies, Michael A.

Ross, Merrick I.

Glitza, Isabella C.

Cormier, Janice N.

Lewis, Carol

Hwu, Wen-Jen

Hanna, Ehab

Diab, Adi

Wong, Michael K.

Royal, Richard

Gross, Neil

Weber, Randal

Lai, Stephen Y.

Ehlers, Richard

Blando, Jorge

Milton, Denai R.

Woodman, Scott

Kageyama, Robin

Wells, Daniel K.

Hwu, Patrick

Patel, Sapna P.

Lucci, Anthony

Hessel, Amy

Lee, Jeffrey E.

Gershenwald, Jeffrey

Simpson, Lauren

Burton, Elizabeth M.

Posada, Liberty

Haydu, Lauren

Wang, Linghua

Zhang, Shaojun

Lazar, Alexander J.

Hudgens, Courtney W.

Gopalakrishnan, Vancheswaran

Reuben, Alexandre

Andrews, Miles C.

Spencer, Christine N.

Prieto, Victor

Sharma, Padmanee

Allison, James

Tetzlaff, Michael T.

Wargo, Jennifer A.

机构：

[1] MD Anderson Cancer Center,Department of Melanoma Medical Oncology

[2] MD Anderson Cancer Center,Department of Breast Medical Oncology

[3] MD Anderson Cancer Center,Department of Surgical Oncology

[4] MD Anderson Cancer Center,Department of Head and Neck Surgery

[5] MD Anderson Cancer Center,Department of Immunology

[6] MD Anderson Cancer Center,Department of Biostatistics

[7] Parker Institute for Cancer Immunotherapy,Department of Genomic Medicine

[8] MD Anderson Cancer Center,Department of Pathology

[9] MD Anderson Cancer Center,Department of Genitourinary Cancers

[10] MD Anderson Cancer Center,Department of Translational and Molecular Pathology

[11] MD Anderson Cancer Center,undefined

来源：

NATURE MEDICINE | 2018年 / 24卷 / 12期

关键词：

D O I：

10.1038/s41591-018-0252-y

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In the version of this article originally published, there was an error in Fig. 1. In the neoadjuvant phase column, the n values for arms A and B were both reported to be 20. The n values for arms A and B were actually 12 and 11, respectively. Also, the URL underlying the accession code in the data availability section was incorrect. The URL was originally https://www.ebi.ac.uk/ega/studies/EGAS00001002698. It should have been https://www.ebi.ac.uk/ega/studies/EGAS00001003178. The errors have been corrected in the print, HTML and PDF versions of this article.

引用

页码：1942 / 1942

页数：1

共 50 条

[1] Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Rodabe N. Amaria
Sangeetha M. Reddy
Hussein A. Tawbi
Michael A. Davies
Merrick I. Ross
Isabella C. Glitza
Janice N. Cormier
Carol Lewis
Wen-Jen Hwu
Ehab Hanna
Adi Diab
Michael K. Wong
Richard Royal
Neil Gross
Randal Weber
Stephen Y. Lai
Richard Ehlers
Jorge Blando
Denái R. Milton
Scott Woodman
Robin Kageyama
Daniel K. Wells
Patrick Hwu
Sapna P. Patel
Anthony Lucci
Amy Hessel
Jeffrey E. Lee
Jeffrey Gershenwald
Lauren Simpson
Elizabeth M. Burton
Liberty Posada
Lauren Haydu
Linghua Wang
Shaojun Zhang
Alexander J. Lazar
Courtney W. Hudgens
Vancheswaran Gopalakrishnan
Alexandre Reuben
Miles C. Andrews
Christine N. Spencer
Victor Prieto
Padmanee Sharma
James Allison
Michael T. Tetzlaff
Jennifer A. Wargo
Nature Medicine, 2018, 24 : 1649 - 1654
[2] Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Amaria, Rodabe N.
Reddy, Sangeetha M.
Tawbi, Hussein A.
Davies, Michael A.
Ross, Merrick, I
Glitza, Isabella C.
Cormier, Janice N.
Lewis, Carol
Hwu, Wen-Jen
Hanna, Ehab
Diab, Adi
Wong, Michael K.
Royal, Richard
Gross, Neil
Weber, Randal
Lai, Stephen Y.
Ehlers, Richard
Blando, Jorge
Milton, Denai R.
Woodman, Scott
Kageyama, Robin
Wells, Daniel K.
Hwu, Patrick
Patel, Sapna P.
Lucci, Anthony
Hessel, Amy
Lee, Jeffrey E.
Gershenwald, Jeffrey
Simpson, Lauren
Burton, Elizabeth M.
Posada, Liberty
Haydu, Lauren
Wang, Linghua
Zhang, Shaojun
Lazar, Alexanderj
Hudgens, Courtney W.
Gopalakrishnan, Vancheswaran
Reuben, Alexandre
Andrews, Miles C.
Spencer, Christine N.
Prieto, Victor
Sharma, Padmanee
Allison, James
Tetzlaff, Michael T.
Wargo, Jennifer A.
NATURE MEDICINE, 2018, 24 (11) : 1649 - +
[3] Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Rodabe N. Amaria
Sangeetha M. Reddy
Hussein A. Tawbi
Michael A. Davies
Merrick I. Ross
Isabella C. Glitza
Janice N. Cormier
Carol Lewis
Wen-Jen Hwu
Ehab Hanna
Adi Diab
Michael K. Wong
Richard Royal
Neil Gross
Randal Weber
Stephen Y. Lai
Richard Ehlers
Jorge Blando
Denái R. Milton
Scott Woodman
Robin Kageyama
Daniel K. Wells
Patrick Hwu
Sapna P. Patel
Anthony Lucci
Amy Hessel
Jeffrey E. Lee
Jeffrey Gershenwald
Lauren Simpson
Elizabeth M. Burton
Liberty Posada
Lauren Haydu
Linghua Wang
Shaojun Zhang
Alexander J. Lazar
Courtney W. Hudgens
Vancheswaran Gopalakrishnan
Alexandre Reuben
Miles C. Andrews
Christine N. Spencer
Victor Prieto
Padmanee Sharma
James Allison
Michael T. Tetzlaff
Jennifer A. Wargo
Nature Medicine, 2018, 24 : 1942 - 1942
[4] Neoadjuvant (neo) immune checkpoint blockade (ICB) in patients (Pts) with high-risk resectable metastatic melanoma (MM)
Amaria, Rodabe Navroze
Reddy, Sangeetha Meda
Tawbi, Hussein Abdul-Hassan
Davies, Michael A.
Ross, Merrick I.
Glitza, Isabella Claudia
Cormier, Janice N.
Lewis, Carol M.
Hwu, Wen-Jen
Hanna, Ehab Y.
Diab, Adi
Wong, Michael K. K.
Royal, Richard Eldon
Gross, Neil D.
Weber, Randal S.
Lai, Stephen Yenzen
Ehlers, Richard A.
Burton, Elizabeth M.
Tetzlaff, Michael T.
Wargo, Jennifer Ann
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[5] Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma (vol 24, pg 1545, 2018)
Auslander, Noam
Zhang, Gao
Lee, Joo Sang
Frederick, Dennie T.
Miao, Benchun
Moll, Tabea
Tian, Tian
Wei, Zhi
Madan, Sanna
Sullivan, Ryan J.
Boland, Genevieve
Flaherty, Keith
Herlyn, Meenhard
Ruppin, Eytan
NATURE MEDICINE, 2018, 24 (12) : 1942 - 1942
[6] Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma
Ferraresi, Virginia
Vari, Sabrina
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (03)
[7] Neoadjuvant immune-checkpoint blockade in resectable colon cancer
George Coukos
Nature Medicine, 2020, 26 : 473 - 474
[8] Neoadjuvant immune-checkpoint blockade in resectable colon cancer
Coukos, George
NATURE MEDICINE, 2020, 26 (04) : 473 - 474
[9] Predictive factors of neoadjuvant immune checkpoint blockade in melanoma
Sarver, Melissa
Brown, Michael C.
Rhodin, Kristen E.
Salama, April K. S.
Beasley, Georgia M.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (03)
[10] Neoadjuvant Dual Checkpoint Inhibitors vs Anti-PD1 Therapy in High-Risk Resectable Melanoma
Mangla, Ankit
Lee, Chanmi
Mirsky, Matthew M.
Wang, Margaret
Rothermel, Luke D.
Hoehn, Richard
Bordeaux, Jeremy S.
Carrol, Bryan T.
Theuner, Jason
Li, Shawn
Fu, Pingfu
Kirkwood, John M.
JAMA ONCOLOGY, 2024, 10 (05) : 612 - 620

← 1 2 3 4 5 →